Summary:
A clinical research study of an investigational medicine for schizophrenia in subjects with cognitive impairment associated with schizophrenia.
Qualified Participants Must:
Ages 18-55
Be diagnosed with schizophrenia
Currently being treated on an outpatient basis
Qualified Participants May Receive:
Transportation & Compensation at each study visit